During the peer-review process the editor and reviewers write an eLife assessment that summarises the significance of the findings reported in the article (on a scale ranging from landmark to useful) ...

Artesunate is under clinical development by Frantz Viral Therapeutics and currently in Phase II for Human Papillomavirus Infections. According to GlobalData, Phase II drugs for Human Papillomavirus ...